China launched the second of three modules to its permanent space station, in one of the final missions needed to complete the orbiting outpost by year's end.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS